Safety, Tolerability And On-Body Temperature Of A Disposable Heatwrap Device For The Lower Back
NCT ID: NCT01055262
Last Updated: 2012-06-19
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
169 participants
INTERVENTIONAL
2010-01-31
2010-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Heat Wrap Device Safety With Age and Body Fat
NCT01355653
Investigational Air-Activated Adhesive-Backed Heat Patch (3-Cell)
NCT02241057
A Clinical Investigation With BARRIER® EasyWarm®
NCT04813809
Efficacy of Warming Garment in the Perioperative Period With Integrated Chemical Heat Packs to Maintain Normothermia
NCT02905708
Comparison Study of Core Temperature Thermometry Systems
NCT01255865
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Heatwrap 1
Experimental heatwrap device for the lower back
Heatwrap 1
8 hours continuous topically-applied heat
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Heatwrap 1
8 hours continuous topically-applied heat
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Female subjects of child-bearing potential and those who are post-menopausal for less than 2 years must be using a medically-approved method of contraception (i.e., oral, transdermal, or implanted contraceptive hormones, cervical cap, intrauterine device, diaphragm, condom, abstinence, or surgical sterility including partner's vasectomy);
* The subject has a waist-hip circumference of between 27-47 inches inclusive.
Exclusion Criteria
* The subject is diabetic;
* The subject has a history of melanoma, squamous or basal cell carcinoma in the area of application of the lower back and hip;
* The subject has any active skin disease which may contraindicate participation, including eczema, rash, broken or irritated skin, contact dermatitis and atopic dermatitis, or any skin condition that may be aggravated by heat;
* The subject has used (within the previous week) or is using any topical drug or heatwrap or electrical heat pads at the application site; or
* The subject has damaged skin in, or around the test sites which includes sunburn, uneven skin tones, tattoos, scars or other disfiguration at the application site, including an erythema grading of greater than 0 at the application site.
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TC-09-06
Identifier Type: -
Identifier Source: secondary_id
TC-09-06
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.